COMP <GO>
CRM vs ORCL // PIOTROSKI F-SCORE QUALITY
Salesforce, Inc. (NYSE) VS. Oracle Corporation (NYSE) • 15-METRIC TALLY: CRM 5
— ORCL 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: CRM
LAST: $229.17 (-0.75%) • MKT CAP: $191.96B
piotroski-score
7/9
LAST: $130.67 (-6.37%) • MKT CAP: $405.97B
piotroski-score
6/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRM VS. ORCL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRM | ORCL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.28% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.95% | 11.39% | -1.44 | ORCL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.0x | 17.9x | +1.09 | ORCL | /valuation <GO> |
| Free Cash Flow Yield | 7.89% | -7.07% | +14.96 | CRM | /fcf-yield <GO> |
| Operating Margin | 19.88% | 32.12% | -12.24 | ORCL | /operating-margins <GO> |
| Net Profit Margin | 21.99% | 26.36% | -4.37 | ORCL | /net-margins <GO> |
| Revenue Growth (YoY) | 11.23% | 21.62% | -10.39 | ORCL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.77% | 1.53% | -0.76 | ORCL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.58 | 1.54 | +1.04 | CRM | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 6/9 | +1.00 | CRM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 10.87% | 11.57% | -0.70 | CRM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.4 | 45.6 | -3.24 | ORCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.37 | 1.37 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.3x | 16.5x | -2.20 | CRM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $191.96B | $405.97B | -$214.01B | ORCL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRM REV | ORCL REV | CRM GROSS % | ORCL GROSS % | CRM FCF | ORCL FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $67.36B | — | — | — | -$23.69B |
| FY 2025 | $41.52B | $57.40B | 77.7% | — | $14.40B | -$394.0M |
| FY 2024 | $37.90B | $52.96B | 77.2% | — | $12.43B | $11.81B |
| FY 2023 | $34.86B | $49.95B | 75.5% | — | $9.50B | $8.47B |
| FY 2022 | $31.35B | $42.44B | 73.3% | — | $6.31B | $5.03B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRM // BETA 1.37
ORCL // BETA 1.37